• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于性别的差异,自然杀伤 T 细胞在保护 Balb/c 小鼠抵抗饮食诱导的脂肪性肝炎中的作用。

Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice.

机构信息

Department of Cell Death and Proliferation, IIBB, CSIC, IDIBAPS, 08036, Barcelona, Spain.

Departament de Biomedicina, Facultat de Medicina, Universitat de Barcelona, 08036, Barcelona, Spain.

出版信息

Biol Sex Differ. 2023 Nov 14;14(1):85. doi: 10.1186/s13293-023-00569-w.

DOI:10.1186/s13293-023-00569-w
PMID:37964320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10644614/
Abstract

BACKGROUND

Metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent in Western countries, evolving into metabolic dysfunction-associated steatohepatitis (MASH) with a sexual dimorphism. Fertile women exhibit lower MASLD risk than men, which diminishes post-menopause. While NKT-cell involvement in steatohepatitis is debated, discrepancies may stem from varied mouse strains used, predominantly C57BL6/J with Th1-dominant responses. Exploration of steatohepatitis, encompassing both genders, using Balb/c background, with Th2-dominant immune response, and CD1d-deficient mice in the Balb/c background (lacking Type I and Type II NKT cells) can clarify gender disparities and NKT-cell influence on MASH progression.

METHODS

A high fat and choline-deficient (HFCD) diet was used in male and female mice, Balb/c mice or CD1d mice in the Balb/c background that exhibit a Th2-dominant immune response. Liver fibrosis and inflammatory gene expression were measured by qPCR, and histology assessment. NKT cells, T cells, macrophages and neutrophils were assessed by flow cytometry.

RESULTS

Female mice displayed milder steatohepatitis after 6 weeks of HFCD, showing reduced liver damage, inflammation, and fibrosis compared to males. Male Balb/c mice exhibited NKT-cell protection against steatohepatitis whereas CD1d males on HFCD presented decreased hepatoprotection, increased liver fibrosis, inflammation, neutrophilic infiltration, and inflammatory macrophages. In contrast, the NKT-cell role was negligible in early steatohepatitis development in both female mice, as fibrosis and inflammation were similar despite augmented liver damage in CD1d females. Relevant, hepatic type I NKT levels in female Balb/c mice were significantly lower than in male.

CONCLUSIONS

NKT cells exert a protective role against experimental steatohepatitis as HFCD-treated CD1d males had more severe fibrosis and inflammation than male Balb/c mice. In females, the HFCD-induced hepatocellular damage and the immune response are less affected by NKT cells on early steatohepatitis progression, underscoring sex-specific NKT-cell influence in MASH development.

摘要

背景

代谢功能障碍相关脂肪性肝病(MASLD)在西方国家较为普遍,随着代谢功能障碍相关脂肪性肝炎(MASH)的发生,存在性别二态性。生育期女性发生 MASLD 的风险低于男性,而绝经后则降低。虽然 NKT 细胞在脂肪性肝炎中的作用存在争议,但差异可能源于所使用的不同小鼠品系,主要是 C57BL6/J 品系,其具有 Th1 优势反应。使用 Th2 优势免疫反应的 Balb/c 背景和缺乏 CD1d 的 Balb/c 背景(缺乏 I 型和 II 型 NKT 细胞)的雄性和雌性小鼠来探索脂肪性肝炎,可以阐明性别差异和 NKT 细胞对 MASH 进展的影响。

方法

雄性和雌性小鼠使用高脂肪和胆碱缺乏(HFCD)饮食,Balb/c 小鼠或缺乏 CD1d 的 Balb/c 背景下的 CD1d 小鼠,这些小鼠表现出 Th2 优势免疫反应。通过 qPCR 和组织学评估测量肝纤维化和炎症基因表达。通过流式细胞术评估 NKT 细胞、T 细胞、巨噬细胞和中性粒细胞。

结果

雌性小鼠在 HFCD 后 6 周表现出较轻的脂肪性肝炎,与雄性相比,肝损伤、炎症和纤维化程度降低。雄性 Balb/c 小鼠的 NKT 细胞具有抗脂肪性肝炎的保护作用,而 HFCD 处理的 CD1d 雄性小鼠的肝保护作用降低,肝纤维化、炎症、中性粒细胞浸润和炎症性巨噬细胞增加。相反,在雌性小鼠的早期脂肪性肝炎发展中,NKT 细胞的作用可以忽略不计,尽管 CD1d 雌性小鼠的肝损伤增加,但纤维化和炎症相似。相关地,雌性 Balb/c 小鼠的肝内 I 型 NKT 细胞水平明显低于雄性。

结论

NKT 细胞对实验性脂肪性肝炎具有保护作用,因为 HFCD 处理的 CD1d 雄性小鼠的纤维化和炎症比雄性 Balb/c 小鼠更严重。在女性中,HFCD 诱导的肝细胞损伤和免疫反应在早期脂肪性肝炎进展中受 NKT 细胞的影响较小,这突出了性别特异性 NKT 细胞对 MASH 发展的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/10644614/d1a7159f5062/13293_2023_569_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/10644614/91c8aaff93f0/13293_2023_569_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/10644614/5166b9565496/13293_2023_569_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/10644614/e5629c785cf7/13293_2023_569_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/10644614/2c5f25b25348/13293_2023_569_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/10644614/4197896449bb/13293_2023_569_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/10644614/2686b021c7b7/13293_2023_569_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/10644614/d1a7159f5062/13293_2023_569_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/10644614/91c8aaff93f0/13293_2023_569_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/10644614/5166b9565496/13293_2023_569_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/10644614/e5629c785cf7/13293_2023_569_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/10644614/2c5f25b25348/13293_2023_569_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/10644614/4197896449bb/13293_2023_569_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/10644614/2686b021c7b7/13293_2023_569_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/10644614/d1a7159f5062/13293_2023_569_Fig7_HTML.jpg

相似文献

1
Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice.基于性别的差异,自然杀伤 T 细胞在保护 Balb/c 小鼠抵抗饮食诱导的脂肪性肝炎中的作用。
Biol Sex Differ. 2023 Nov 14;14(1):85. doi: 10.1186/s13293-023-00569-w.
2
A comparative study on roles of natural killer T cells in two diet-induced non-alcoholic steatohepatitis-related fibrosis in mice.两种饮食诱导的非酒精性脂肪性肝炎相关肝纤维化小鼠模型中自然杀伤 T 细胞作用的比较研究。
Ann Med. 2022 Dec;54(1):2233-2245. doi: 10.1080/07853890.2022.2108894.
3
Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.自然杀伤 T 细胞在进行性非酒精性脂肪性肝病中的积累。
Hepatology. 2010 Jun;51(6):1998-2007. doi: 10.1002/hep.23599.
4
Protective Effects of Hepatocyte Stress Defenders, Nrf1 and Nrf2, against MASLD Progression.肝应激防御因子 Nrf1 和 Nrf2 对 MASLD 进展的保护作用。
Int J Mol Sci. 2024 Jul 24;25(15):8046. doi: 10.3390/ijms25158046.
5
NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review.非酒精性脂肪性肝病(MASLD)/非酒精性脂肪性肝炎(MASH):是否有必要进行标记?全面的叙述性综述。
Int J Mol Sci. 2024 Aug 2;25(15):8462. doi: 10.3390/ijms25158462.
6
Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice.遗传敲除 STE20 型激酶 MST4 不能减轻小鼠饮食诱导的 MASLD 易感性。
Int J Mol Sci. 2024 Feb 19;25(4):2446. doi: 10.3390/ijms25042446.
7
The Multicomponent Medicinal Product Hepar Compositum Reduces Hepatic Inflammation and Fibrosis in a Streptozotocin- and High-Fat Diet-Induced Model of Metabolic Dysfunction-Associated Steatotic Liver Disease/Metabolic Dysfunction-Associated Steatohepatitis.多成分药物复合肝制剂在链脲佐菌素和高脂饮食诱导的代谢功能障碍相关脂肪性肝病/代谢功能障碍相关脂肪性肝炎模型中可减轻肝脏炎症和纤维化。
Biomedicines. 2023 Dec 4;11(12):3216. doi: 10.3390/biomedicines11123216.
8
Choline-deficient, high-fat diet-induced MASH in Göttingen Minipigs: characterization and effects of a chow reversal period.胆碱缺乏、高脂肪饮食诱导的哥廷根小型猪 MASH:特征描述及膳食逆转期的影响。
Am J Physiol Gastrointest Liver Physiol. 2024 Oct 1;327(4):G571-G585. doi: 10.1152/ajpgi.00120.2024. Epub 2024 Jul 23.
9
Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice.细胞核内的miR-204-3p可减轻小鼠代谢功能障碍相关脂肪性肝病。
J Hepatol. 2024 Jun;80(6):834-845. doi: 10.1016/j.jhep.2024.01.029. Epub 2024 Feb 6.
10
NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease.NKT 相关的 hedgehog 和骨桥蛋白驱动非酒精性脂肪性肝病中的纤维化。
Gut. 2012 Sep;61(9):1323-9. doi: 10.1136/gutjnl-2011-301857. Epub 2012 Mar 17.

引用本文的文献

1
GLP-1/GLP-1R axis: from metabolism (obesity and T2DM) to immunity.胰高血糖素样肽-1/胰高血糖素样肽-1受体轴:从代谢(肥胖症和2型糖尿病)到免疫
Open Biol. 2025 Jan;15(7):240303. doi: 10.1098/rsob.240303. Epub 2025 Jul 2.
2
Non-parenchymal cells: key targets for modulating chronic liver diseases.非实质细胞:调节慢性肝病的关键靶点。
Front Immunol. 2025 Jun 11;16:1576739. doi: 10.3389/fimmu.2025.1576739. eCollection 2025.
3
p53 and TIGAR promote redox control to protect against metabolic dysfunction-associated steatohepatitis.p53和TIGAR促进氧化还原调控以预防代谢功能障碍相关脂肪性肝炎。

本文引用的文献

1
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家组关于新的脂肪肝疾病命名的德尔菲共识声明。
J Hepatol. 2023 Dec;79(6):1542-1556. doi: 10.1016/j.jhep.2023.06.003. Epub 2023 Jun 24.
2
Research Priorities for Precision Medicine in NAFLD.非酒精性脂肪性肝病精准医学研究重点。
Clin Liver Dis. 2023 May;27(2):535-551. doi: 10.1016/j.cld.2023.01.016. Epub 2023 Feb 26.
3
Obesogenic and diabetic effects of CD44 in mice are sexually dimorphic and dependent on genetic background.CD44 在小鼠中的致肥胖和致糖尿病作用具有性别二态性,且依赖于遗传背景。
JHEP Rep. 2025 Mar 20;7(7):101397. doi: 10.1016/j.jhepr.2025.101397. eCollection 2025 Jul.
4
Association of High-Density Lipoprotein Cholesterol-Based Inflammatory Markers With MASLD and Significant Liver Fibrosis in US Adults: Insights From NHANES 2017-2020.美国成年人中基于高密度脂蛋白胆固醇的炎症标志物与代谢功能障碍相关脂肪性肝病及显著肝纤维化的关联:来自2017 - 2020年美国国家健康与营养检查调查的见解
Clin Transl Gastroenterol. 2025 Jun 16. doi: 10.14309/ctg.0000000000000873.
5
Anti-Tumour Immunity Relies on Targeting Tissue Homeostasis Through Monocyte-Driven Responses Rather Than Direct Tumour Cytotoxicity.抗肿瘤免疫依赖于通过单核细胞驱动的反应靶向组织稳态,而非直接的肿瘤细胞毒性。
Liver Int. 2025 May;45(5):e70110. doi: 10.1111/liv.70110.
6
Hepatic immune regulation and sex disparities.肝脏免疫调节与性别差异。
Nat Rev Gastroenterol Hepatol. 2024 Dec;21(12):869-884. doi: 10.1038/s41575-024-00974-5. Epub 2024 Sep 5.
7
Anti-tumor immunity relies on targeting tissue homeostasis through monocyte-driven responses rather than direct tumor cytotoxicity.抗肿瘤免疫依赖于通过单核细胞驱动的反应来靶向组织稳态,而非直接的肿瘤细胞毒性。
bioRxiv. 2025 Mar 6:2024.06.12.598563. doi: 10.1101/2024.06.12.598563.
8
Fatty Liver Index (FLI) is the best score to predict MASLD with 50% lower cut-off value in women than in men.脂肪肝指数(FLI)是预测 MASLD 的最佳评分,女性的截断值比男性低 50%。
Biol Sex Differ. 2024 May 17;15(1):43. doi: 10.1186/s13293-024-00617-z.
9
GAS6/TAM Axis as Therapeutic Target in Liver Diseases.Gas6/TAM 轴作为肝脏疾病的治疗靶点。
Semin Liver Dis. 2024 Feb;44(1):99-114. doi: 10.1055/a-2275-0408. Epub 2024 Feb 23.
Biol Sex Differ. 2022 Apr 11;13(1):14. doi: 10.1186/s13293-022-00426-2.
4
Advancing the global public health agenda for NAFLD: a consensus statement.推进非酒精性脂肪性肝病的全球公共卫生议程:共识声明。
Nat Rev Gastroenterol Hepatol. 2022 Jan;19(1):60-78. doi: 10.1038/s41575-021-00523-4. Epub 2021 Oct 27.
5
Preparing for the NASH Epidemic: A Call to Action.应对 NASH 流行:行动呼吁。
Gastroenterology. 2021 Sep;161(3):1030-1042.e8. doi: 10.1053/j.gastro.2021.04.074. Epub 2021 Jul 26.
6
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Lancet. 2021 Jun 5;397(10290):2212-2224. doi: 10.1016/S0140-6736(20)32511-3. Epub 2021 Apr 21.
7
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis.2018 年五个欧洲国家诊断为非酒精性脂肪性肝炎的疾病负担和经济影响:疾病成本分析。
Liver Int. 2021 Jun;41(6):1227-1242. doi: 10.1111/liv.14825. Epub 2021 Mar 18.
8
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism.肥胖与非酒精性脂肪性肝病中的巨噬细胞:与代谢的相互作用
JHEP Rep. 2019 Feb 23;1(1):30-43. doi: 10.1016/j.jhepr.2019.02.004. eCollection 2019 May.
9
Inflammatory Phenotype of Intrahepatic Sulfatide-Reactive Type II NKT Cells in Humans With Autoimmune Hepatitis.自身免疫性肝炎患者肝内硫脂反应性 II 型 NKT 细胞的炎症表型。
Front Immunol. 2019 May 28;10:1065. doi: 10.3389/fimmu.2019.01065. eCollection 2019.
10
Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps.非酒精性脂肪性肝病的性别差异:现状与研究空白的识别。
Hepatology. 2019 Oct;70(4):1457-1469. doi: 10.1002/hep.30626. Epub 2019 Sep 23.